Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPTIFIBATIDE vs ERENUMAB-AOOE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPTIFIBATIDE vs ERENUMAB-AOOE: Safety Overview

Metric EPTIFIBATIDE ERENUMAB-AOOE
Total FAERS Reports 462 50,133
Deaths Reported 57 1,935
Death Rate 12.3% 3.9%
Hospitalizations 143 3,054
Average Patient Age 57.2 yrs 50.2 yrs
% Female Patients 30.9% 86.2%
FDA Approval Date Apr 18, 2017 N/A
Manufacturer Slate Run Pharmaceuticals, LLC N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued Prescription